The impact of cisplatinum‐based chemotherapy on ventricular function and cardiovascular risk factors in female survivors after malignant germ cell cancer

AIMS: Among male cancer survivors, cisplatinum‐based chemotherapy (CBCT) is associated with impaired left ventricle (LV) diastolic function, increased risk of metabolic syndrome, and increased cardiovascular morbidity and mortality. Comparable data in females are limited. The long‐term effects of ci...

Descripción completa

Detalles Bibliográficos
Autores principales: Murbraech, Klaus, Solheim, Olesya, Aulie, Hanne M., Fossa, Sophie D., Aakhus, Svend
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410543/
https://www.ncbi.nlm.nih.gov/pubmed/28834675
http://dx.doi.org/10.1002/ehf2.12048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410543/
https://www.ncbi.nlm.nih.gov/pubmed/28834675
http://dx.doi.org/10.1002/ehf2.12048

Ejemplares similares